Company Financials

Cytokinetics, Incorporated Financials

United States dollar

business Cytokinetics, Incorporated Company Profile

Main Stock Listing

NASDAQ: CYTK

Market Capitalization $7.55 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -11.74
Forward PE -10.53
Price to Sales TTM $86.54
Price to Book MRQ $-14.21
Enterprise to Revenue 90.99
Enterprise to EBITDA -14.09

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -1737.22%
Operating Margin -8613.38%
Return on Assets TTM -24.93%
Return on Equity TTM 435.49%

Income Statement

Revenue TTM $87,211,000
Revenue per Share TTM $0.73
Quarterly Revenue Growth 318.10%
Gross Profit TTM $-318,046,016
EBITDA $-563,284,992
Net Income to Common TTM $-751,944,000
Diluted EPS TTM $-6.30
Quarterly Earnings Growth YoY 318.14%

Balance Sheet

Total Cash MRQ $962,534,976
Total Cash per Share MRQ $7.87
Total Debt MRQ $
Total Debt to Equity MRQ -2.59
Current Ratio MRQ 6.88
Book Value per Share MRQ $-4.26

Cash Flow

Operating Cash Flow TTM $-432,928,000
Levered Free Cash Flow TTM $-320,961,888

CYTK Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 122,119,460
Float Shares 121,674,389
Avg 10 Volume 2,460,310
Avg 30 Volume None
Shares Short 13,341,806
Short Ratio 7.60
Short % of Shares 14.13%
% Held by Insiders 0.74%
% Held by Institutions 118.34%

Stock Price Summary

Beta 0.59
Fifty Two Week Low $29.31
Fifty Two Week High $70.98
Fifty Two Week Change 20.31%
Day 50 MA $63.00
Day 200 MA $46.05

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2013-06-25